Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Human CD4+CD8α+ Tregs induced by Faecalibacterium prausnitzii protect against intestinal inflammation
Sothea Touch, … , Frédéric Altare, Harry Sokol
Sothea Touch, … , Frédéric Altare, Harry Sokol
Published May 10, 2022
Citation Information: JCI Insight. 2022;7(12):e154722. https://doi.org/10.1172/jci.insight.154722.
View: Text | PDF
Research Article Gastroenterology

Human CD4+CD8α+ Tregs induced by Faecalibacterium prausnitzii protect against intestinal inflammation

  • Text
  • PDF
Abstract

Abundance of Faecalibacterium prausnitzii, a dominant bacterium of the human microbiota that exhibits antiinflammatory effects, is decreased in patients with inflammatory bowel diseases (IBD). In humans, colonic lamina propria contains IL-10–secreting, Foxp3– Tregs characterized by a double expression of CD4 and CD8α (DP8α) and a specificity for F. prausnitzii. This Treg subset is decreased in IBD. The in vivo effect of DP8α cells has not been evaluated yet to our knowledge. Here, using a humanized model of a NSG immunodeficient mouse strain that expresses the HLA D–related allele HLA-DR*0401 but not murine class II (NSG-Ab° DR4) molecules, we demonstrated a protective effect of a HLA-DR*0401–restricted DP8α Treg clone combined with F. prausnitzii administration in a colitis model. In a cohort of patients with IBD, we showed an independent association between the frequency of circulating DP8α cells and disease activity. Finally, we pointed out a positive correlation between F. prausnitzii–specific DP8α Tregs and the amount of F. prausnitzii in fecal microbiota in healthy individuals and patients with ileal Crohn’s disease.

Authors

Sothea Touch, Emmanuelle Godefroy, Nathalie Rolhion, Camille Danne, Cyriane Oeuvray, Marjolène Straube, Chloé Galbert, Loïc Brot, Iria Alonso Salgueiro, Sead Chadi, Tatiana Ledent, Jean-Marc Chatel, Philippe Langella, Francine Jotereau, Frédéric Altare, Harry Sokol

×

Total citations by year

Year: 2025 2024 2023 2022 Total
Citations: 5 13 5 3 26
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (26)

Title and authors Publication Year
The Critical Role of Faecalibacterium prausnitzii in Cardiovascular Diseases
Zheng T, Meng C, Lv Z, Wu C, Zhou X, Mao W
Reviews in Cardiovascular Medicine 2025
Coevolutionary interplay: Helminths-trained immunity and its impact on the rise of inflammatory diseases
Carrera Silva EA, Puyssegur J, Errasti AE
eLife 2025
Gut–Brain Inflammatory Pathways in Attention-Deficit/Hyperactivity Disorder: The Role and Therapeutic Potential of Diet
Lewis N, Lagopoulos J, Villani A
Metabolites 2025
Gut microbiome and metabolome interactions in Crohn’s disease: mechanistic insights into exclusive enteral nutrition-induced remission
Zheng W, Zhou Q, Xue M, Yu X, Chen X, Chen J, Wang C
Frontiers in Microbiology 2025
Interplay of Gut Microbiota, Biologic Agents, and Postoperative Anastomotic Leakage in Inflammatory Bowel Disease: A Narrative Review
Menni AE, Kyriazopoulou E, Karakike E, Tzikos G, Filidou E, Kotzampassi K
International Journal of Molecular Sciences 2025
Human gut microbiota-reactive DP8a regulatory T cells prevent graft-versus-host disease in a CD73-dependent manner
Emmanuelle Godefroy, Patrice Chevallier, Fabienne Haspot, Caroline Vignes, veronique daguin, Sylvia Lambot, Margaux Verdon, Margaux Seilhac, Anne Jarry, Annabelle Pédron, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Valentin Letailleur, Marie-Anne Vibet, Maxence Mougon, Amandine Bourgeois, Maxime Jullien, Francine Jotereau, Frédéric Altare
JCI Insight 2024
Faecalibacterium prausnitzii as a potential Antiatherosclerotic microbe.
Yang HT, Jiang ZH, Yang Y, Wu TT, Zheng YY, Ma YT, Xie X
Cell communication and signaling : CCS 2024
The dynamic shifts of IL-10-producing Th17 and IL-17-producing Treg in health and disease: a crosstalk between ancient "Yin-Yang" theory and modern immunology.
Cui H, Wang N, Li H, Bian Y, Wen W, Kong X, Wang F
Cell communication and signaling : CCS 2024
Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial
Alves Costa Silva C, Piccinno G, Suissa D, Bourgin M, Schreibelt G, Durand S, Birebent R, Fidelle M, Sow C, Aprahamian F, Manghi P, Punčochář M, Asnicar F, Pinto F, Armanini F, Terrisse S, Routy B, Drubay D, Eggermont AM, Kroemer G, Segata N, Zitvogel L, Derosa L, Bol KF, de Vries IJ
Nature Communications 2024
Solobacterium moorei promotes the progression of adenomatous polyps by causing inflammation and disrupting the intestinal barrier.
Yu S, Wang X, Li Z, Jin D, Yu M, Li J, Li Y, Liu X, Zhang Q, Liu Y, Liu R, Wang X, Fang B, Zhang C, Wang R, Ren F
Journal of Translational Medicine 2024
The Plethora of Microbes with Anti-Inflammatory Activities
Tsvetanova F
International journal of molecular sciences 2024
Faecalibacterium duncaniae as a novel next generation probiotic against influenza.
Chollet L, Heumel S, Deruyter L, Bouilloux F, Delval L, Robert V, Gevaert MH, Pichavant M, Sencio V, Robil C, Wolowczuk I, Sokol H, Auger S, Douablin A, Langella P, Chatel JM, Grangette C, Trottein F
Frontiers in immunology 2024
Faecalibacterium prausnitzii Supplementation Prevents Intestinal Barrier Injury and Gut Microflora Dysbiosis Induced by Sleep Deprivation
Wang X, Li Y, Wang X, Wang R, Hao Y, Ren F, Wang P, Fang B
Nutrients 2024
Probiotics: Shaping the gut immunological responses.
Filidou E, Kandilogiannakis L, Shrewsbury A, Kolios G, Kotzampassi K
World Journal of Gastroenterology 2024
The Gut and the Translocated Microbiomes in HIV Infection: Current Concepts and Future Avenues
Nganou-Makamdop K, Douek DC
Pathogens and Immunity 2024
Faecalibaterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors
Bredon M, Danne C, Pham HP, Ruffié P, Bessede A, Rolhion N, Creusot L, Brot L, Alonso I, Langella P, Derosa L, Cortot AB, Routy B, Zitvogel L, Segata N, Sokol H
OncoImmunology 2024
Enhanced microbiota profiling in patients with quiescent Crohn’s disease through comparison with paired healthy first-degree relatives
Chen W, Li Y, Wang W, Gao S, Hu J, Xiang B, Wu D, Jiao N, Xu T, Zhi M, Zhu L, Zhu R
Cell reports. Medicine 2024
Exploring the Role of the Gut Microbiota in Modulating Colorectal Cancer Immunity
Shakhpazyan NK, Mikhaleva LM, Bedzhanyan AL, Gioeva ZV, Mikhalev AI, Midiber KY, Pechnikova VV, Biryukov AE
Cells 2024
Microbiota-induced regulatory T cells associate with FUT2-dependent susceptibility to rotavirus gastroenteritis
Godefroy E, Barbé L, Le Moullac-Vaidye B, Rocher J, Breiman A, Leuillet S, Mariat D, Chatel JM, Ruvoën-Clouet N, Carton T, Jotereau F, Le Pendu J
Frontiers in microbiology 2023
Alleviative Effect of Probiotic Ferment on Lawsonia intracellularis Infection in Piglets
Xu T, Guo Y, Zhang Y, Cao K, Zhou X, Qian M, Han X
Biology 2023
Faecalibacterium: a bacterial genus with promising human health applications
Martín R, Rios-Covian D, Huillet E, Auger S, Khazaal S, Bermúdez-Humarán LG, Sokol H, Chatel JM, Langella P
FEMS Microbiology Reviews 2023
Neutrophils: from IBD to the gut microbiota.
Danne C, Skerniskyte J, Marteyn B, Sokol H
Nature reviews. Gastroenterology & hepatology 2023
Faecalibacterium duncaniae A2‐165 growth is strongly promoted by yeast extract and vitamin B5 in cGMP medium
Bircher L, Sourabié AM, Paurevic M, Hochuli J, Geirnaert A, Navas C, Drogue B, Lacroix C
Microbial Biotechnology 2023
Supplementation with honeysuckle extract improves growth performance, immune performance, gut morphology, and cecal microbes in geese
Li G, Wang X, Liu Y, Wang C, Yang Y, Gong S, Zhu L, He D, Wang H
Frontiers in Veterinary Science 2022
Human gut microbiota-reactive DP8α regulatory T cells, signature and related emerging functions
Jotereau F, Alameddine J, Teusan R, Pédron A, Jouand N, Altare F, Godefroy E
Frontiers in immunology 2022
Intestinal bacterial community composition of juvenile Chinese mitten crab Eriocheir sinensis under different feeding times in lab conditions.
Xu Y, Huang Z, Zhang B, Yu C, Li L, Li X, Li Y
Scientific Reports 2022

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts